Krystal Biotech, Inc. Proceeds from Convertible Debt
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2018-11-05
- Krystal Biotech, Inc. proceeds from convertible debt for the quarter ending 2017-12-31 was $0.00.
- Krystal Biotech, Inc. proceeds from convertible debt for the quarter ending 2017-09-30 was $0.00.
- Krystal Biotech, Inc. proceeds from convertible debt for the quarter ending 2017-06-30 was $999.00K.
- Krystal Biotech, Inc. proceeds from convertible debt for the quarter ending 2017-03-31 was $300.00K.
- Krystal Biotech, Inc. proceeds from convertible debt for fiscal 2017 was $1.30M, a 13.45% increase from fiscal 2016.
- Krystal Biotech, Inc. proceeds from convertible debt for fiscal 2016 was $1.15M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 9 month as first filed | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $999.00K derived: sum of 3 quarters · filed 2018-11-05 | $1.30M 10-K · filed 2018-03-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $999.00K derived: sum of 2 quarters · filed 2018-11-05 | $1.30M 10-Q · filed 2018-11-05 | $2.30M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.30M 10-Q · filed 2018-08-06 | |||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-07 | ||||
| 2016-12-31 | $1.15M 10-K · filed 2018-03-12 |